Conversation tool to help people make lung cancer decisions
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a low-reading-level conversation tool meant to help people with suspected lung cancer understand and make treatment decisions with their clinicians. It may help by making discussions clearer and easier to follow.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have suspected lung cancer (you are being evaluated for it).
- You can speak and understand English well enough to join the conversations.
- Your healthcare team expects you may live more than 6 months.
- You may have trouble with thinking or memory, based on a screening score of 3 or higher.
- You (as a participant) would join the conversation tool process that clinicians use during lung cancer decision discussions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program to help people in tribal communities get screened for lung cancer. It may help you get a low-dose CT scan to check for lung cancer early, when it’s easier to treat.
This study is testing whether a centralized support program helps people get regular lung cancer screening. If you are at risk for lung cancer and have had a screening CT scan at one of the participating health centers, this study may help improve care.
This trial tests whether trained advocates and supporters can help people who are eligible for lung cancer screening actually get screened. It may help you (and others) by making screening easier to plan and complete.
This study tests a new questionnaire to help people with advanced lung cancer better understand their illness. It is for patients who are being treated at MD Anderson and were recently diagnosed.
This trial tests an educational approach delivered through tobacco quitlines to encourage eligible smokers to learn about lung cancer screening. It may help people who have a heavy smoking history get the right information and next steps.
This study is testing a tool to help you and your doctor make decisions together about whether to have extra treatment after surgery for non-small cell lung cancer (stage 1B or higher). It only includes patients at Mayo Clinic in Rochester who are eligible for that extra treatment.
Hear when a new Lung Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.